Kwangdong Healthbio Overview
- Year Founded
-
1992
- Status
-
Public
- Employees
-
194
- Stock Symbol
-
086220
- Investments
-
1
- Share Price
-
$0.90
- (As of Friday Closing)
Kwangdong Healthbio General Information
Description
Kwangdong Healthbio Co Ltd formerly BL Healthcare Corp is a Bio-venture company, which develops, manufactures, and sells health functional food and pharmaceutical products. The Company's products include weight-loss pills, vitamins, and other nutrition supplements. It also produces personal care items such as cosmetics, hair care products, and skincare products.
Contact Information
Website
www.kdhealthbio.comCorporate Office
- 39, Yangcheongsongdae-gil Ochang-eup
- Cheongwon-gu
- Cheongju, Chungcheongbuk 28118
- South Korea
Corporate Office
- 39, Yangcheongsongdae-gil Ochang-eup
- Cheongwon-gu
- Cheongju, Chungcheongbuk 28118
- South Korea
Kwangdong Healthbio Stock Performance
As of 13-Nov-2026, Kwangdong Healthbio’s stock price is $0.90. Its current market cap is $9.5M.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.90 | $0.81 | $0.41 - $1.17 | $9.5M | 210.26 | -$0.04 |
Kwangdong Healthbio Financials Summary
As of 31-Dec-2025, Kwangdong Healthbio has a trailing 12-month revenue of $47.1M.
|
In Thousands, USD |
TTM 31-Dec-2025 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 27,647 | 27,647 | 27,874 | 42,903 |
| Revenue | 47,065 | 47,065 | 48,006 | 61,308 |
| EBITDA | 2,569 | 2,569 | 1,286 | 3,684 |
| Net Income | (450) | (450) | (1,437) | 436 |
| Total Assets | 43,199 | 43,199 | 35,940 | 44,152 |
| Total Debt | 19,735 | 19,735 | 17,241 | 21,212 |
Kwangdong Healthbio Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Kwangdong Healthbio Patents
Kwangdong Healthbio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2017018791-A1 | Ginseng fruit extract containing alcoholic liver damage preventive functional ingredient, and preparation method therefor | Inactive | 27-Jul-2015 | ||
| WO-2007091801-A1 | A sheet device comprising bio-cellulose for alleviating skin damage and relieving skin problem | Inactive | 07-Feb-2006 | ||
| WO-2005067940-A1 | Novel use of water soluble glucan oligomer isolated from saccharomyces cerevisiae is2 for prevention and treatment of avian flu | Inactive | 19-Jan-2004 | ||
| WO-2005044291-A1 | Grape seed extract having neuronal cell-protecting activity and the composition comprising the same for prepenting and treating degenerative brain disease | Inactive | 07-Nov-2003 | ||
| US-20070122504-A1 | Grape seed extract having neuronal cell-protection activity and the composition comprising the same for preventing and treating degenerative brain disease | Inactive | 07-Nov-2003 | A61K36/87 |
Kwangdong Healthbio Signals
Kwangdong Healthbio Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Kwangdong Healthbio Investments (1)
Kwangdong Healthbio’s most recent deal was a Corporate Asset Purchase with UID (21898.2 Square Meters Facility Site in Cheongju, South Korea) for . The deal was made on 04-Nov-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| UID (21898.2 Square Meters Facility Site in Cheongju, South Korea) | 04-Nov-2019 | Corporate Asset Purchase | Buildings and Property |
Kwangdong Healthbio ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Food Products
Industry
Rank
Percentile
Packaged Foods
Subindustry
Rank
Percentile
Kwangdong Healthbio FAQs
-
When was Kwangdong Healthbio founded?
Kwangdong Healthbio was founded in 1992.
-
Where is Kwangdong Healthbio headquartered?
Kwangdong Healthbio is headquartered in Cheongju, South Korea.
-
What is the size of Kwangdong Healthbio?
Kwangdong Healthbio has 194 total employees.
-
What industry is Kwangdong Healthbio in?
Kwangdong Healthbio’s primary industry is Pharmaceuticals.
-
Is Kwangdong Healthbio a private or public company?
Kwangdong Healthbio is a Public company.
-
What is Kwangdong Healthbio’s stock symbol?
The ticker symbol for Kwangdong Healthbio is 086220.
-
What is the current stock price of Kwangdong Healthbio?
As of 13-Nov-2026 the stock price of Kwangdong Healthbio is $0.90.
-
What is the current market cap of Kwangdong Healthbio?
The current market capitalization of Kwangdong Healthbio is $9.5M.
-
What is Kwangdong Healthbio’s current revenue?
The trailing twelve month revenue for Kwangdong Healthbio is $47.1M.
-
What is Kwangdong Healthbio’s annual earnings per share (EPS)?
Kwangdong Healthbio’s EPS for 12 months was -$0.04.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process